Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Proteasome | R-HSA-68819 | map03050 | haloperidol | 3559 | drug-path |
| Complement and coagulation cascades | R-HSA-114591 | map04610 | haloperidol | 3559 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | sulfadiazine | 5280793 | drug-path |
| Shigellosis | 0 | map05131 | sulfadiazine | 5280793 | drug-path |
| Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | sulfadiazine | 5280793 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | sulfadiazine | 5280793 | drug-path |
| Circadian rhythm - mammal | R-HSA-400253 | 0 | sulfadiazine | 5280793 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | sulfadiazine | 5280793 | drug-path |
| Small cell lung cancer | R-HSA-5619066 | map05222 | sulfadiazine | 5280793 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | diprophylline | 3182 | drug-path |
| Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | diprophylline | 3182 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | diprophylline | 3182 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | diprophylline | 3182 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | diprophylline | 3182 | drug-path |
| Asthma | R-HSA-444620 | map05310 | diprophylline | 3182 | drug-path |
| Jak-STAT signaling pathway | R-HSA-168638 | map04630 | diprophylline | 3182 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | diprophylline | 3182 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | diprophylline | 3182 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | diprophylline | 3182 | drug-path |
| Adherens junction | R-HSA-451386 | map04520 | triamterene | 5546 | drug-path |